205 related articles for article (PubMed ID: 9641885)
21. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
[No Abstract] [Full Text] [Related]
22. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer in 1988. Possibilities and probabilities.
Warshaw AL; Swanson RS
Ann Surg; 1988 Nov; 208(5):541-53. PubMed ID: 2461172
[TBL] [Abstract][Full Text] [Related]
24. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer.
Gobbi PG; Bergonzi M; Comelli M; Villano L; Pozzoli D; Vanoli A; Dionigi P
Cancer Epidemiol; 2013 Apr; 37(2):186-90. PubMed ID: 23369450
[TBL] [Abstract][Full Text] [Related]
26. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis.
Tannapfel A; Wittekind C; Hünefeld G
Int J Pancreatol; 1992 Oct; 12(2):145-52. PubMed ID: 1460329
[TBL] [Abstract][Full Text] [Related]
27. Current management of pancreatic carcinoma.
Lillemoe KD
Ann Surg; 1995 Feb; 221(2):133-48. PubMed ID: 7531966
[TBL] [Abstract][Full Text] [Related]
28. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?].
Böttger T; Boddin J; Küchle R; Junginger T
Langenbecks Arch Chir; 1997; 382(4):209-15. PubMed ID: 9445967
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer.
Yeo CJ; Cameron JL
Curr Probl Surg; 1999 Feb; 36(2):59-152. PubMed ID: 10021685
[No Abstract] [Full Text] [Related]
30. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative radiotherapy for pancreatic adenocarcinoma.
Sunamura M; Kobari M; Lozonschi L; Egawa S; Matsuno S
J Hepatobiliary Pancreat Surg; 1998; 5(2):151-6. PubMed ID: 9745081
[TBL] [Abstract][Full Text] [Related]
32. What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?
Santi I; Brandt A; Hemminki K
Ann Surg Oncol; 2011 Jan; 18(1):300-1. PubMed ID: 20589435
[No Abstract] [Full Text] [Related]
33. Pathology and biology of pancreatic ductal adenocarcinoma.
Hermanek P
Langenbecks Arch Surg; 1998 Apr; 383(2):116-20. PubMed ID: 9641883
[TBL] [Abstract][Full Text] [Related]
34. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Tempero MA; Malafa MP; Al-Hawary M; Asbun H; Bain A; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chiorean EG; Chung V; Czito B; Dillhoff M; Dotan E; Ferrone CR; Hardacre J; Hawkins WG; Herman J; Ko AH; Komanduri S; Koong A; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Scaife C; Thayer S; Weekes CD; Wolff RA; Wolpin BM; Burns J; Darlow S
J Natl Compr Canc Netw; 2017 Aug; 15(8):1028-1061. PubMed ID: 28784865
[TBL] [Abstract][Full Text] [Related]
36. [Current diagnosis and treatment of pancreatic cancer].
Heinrich S; Schäfer M; Bauerfeind P; Pestalozzi BC; Clavien PA
Praxis (Bern 1994); 2005 Aug; 94(33):1243-54. PubMed ID: 16138769
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Masao K; Kabuto T; Furukawa H; Imaoka S
Hepatogastroenterology; 1998; 45(21):644-50. PubMed ID: 9684110
[TBL] [Abstract][Full Text] [Related]
38. Variant of ductal adenocarcinoma of pancreas.
Suda K; Nobukawa B; Mogaki M; Fujii H; Matsumoto Y
Pancreas; 1999 Oct; 19(3):318-20. PubMed ID: 10505765
[No Abstract] [Full Text] [Related]
39. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
40. [Locally advanced adenocarcinoma of the pancreas: current therapeutic modalities].
Lombard-Bohas C; Mornex F; Saurin JC
Cancer Radiother; 1997; 1(5):547-54. PubMed ID: 9587388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]